9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Hoffmann-La Roche
Cellectar Biosciences, Inc.
AstraZeneca
Eli Lilly and Company
Deciphera Pharmaceuticals, LLC
Sumitomo Pharma America, Inc.
Nuvation Bio Inc.
Xennials Therapeutics Australia Pty Ltd
Five Prime Therapeutics, Inc.
Shenzhen BinDeBio Ltd.
Laboratorio Elea Phoenix S.A.
INSYS Therapeutics Inc
Envita Medical Center, Inc.
Thallion Pharmaceuticals